Fig. 1From: Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenanceMedian value and inter quartile range of the three evaluated outcoms (prednisone dose, eosinophil count and Brief Fatigue Inventory—BFI) at each time point (baseline—t0—and at the 3rd, 6th and 12th month)Back to article page